Beijing Haidian Hospital

The trials here

What the 12 trials at this site are about, from their registry records.

Conditions

• Chronic kidney disease3 trials
• Lung cancer3 trials
• Coronary artery disease2 trials
• Stroke2 trials
• Macular degeneration1 trial
• Polycystic ovary syndrome1 trial
• Type 2 diabetes1 trial

Status

• Recruiting5 trials
• Completed4 trials
• Not yet recruiting2 trials
• Active, not recruiting1 trial

Lead sponsor

• Beijing Haidian Hospital3 trials
• Vantive Health LLC2 trials
• Amgen1 trial
• Asahi Kasei Therapeutics Corporation1 trial
• Beijing Hospital1 trial
• and 4 more

Running trials

• Recruiting

  Early Identification and Diagnosis of BAD-related Stroke

  NCT07693816· Peking Union Medical College Hospital· Source

  Contact: Zhenghong Zhou

• Recruiting

  Multimodal Ocular Diagnosis-Guided Precision Acupuncture and Lifestyle Intervention for PCOS

  NCT07809503· Peking University Third Hospital· Source

  Contact: Haolin Zhang, PhD

• Recruiting

  Clinical Effectiveness and Resource Use in End-Stage Renal Disease Patients: Remote Patient Monitoring Across Dialysis Modalities

  NCT07781124· Vantive Health LLC· Source

  Contact: Gang Fu

• Recruiting

  Real-world Study of Aflibercept 8 mg in nAMD

  NCT07640997· Peking University People's Hospital· Source

  Contact: Ang Ji

• Recruiting

  LineMatrix® Biological Vascular Graft for the Creation of Arteriovenous Graft

  NCT07773051· Longhua Hospital· Source

  Contact: Yuzhu Wang

• Recruiting

  Application Research of Methylation Markers in Early-stage Lung Cancer Patients Treated With Co-ablation System Therapy

  NCT07257471· Beijing Haidian Hospital· Source

  Contact: Yuqing Huang, Ph.D

• Recruiting

  Application of Methylation Markers in Early Detection and MRD Monitoring of Lung Cancer

  NCT07257458· Beijing Haidian Hospital· Source

  Contact: Yuqing Huang, Ph.D

• Active, not recruiting

  A Study Assessing Repatha® in Combination With Standard of Care (SOC) Compared With SOC on Major Cardiovascular Events in Chinese Participants With Atherosclerotic Cardiovascular Disease

  NCT06295679· Amgen· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Chronic kidney disease2 recruiting
• Lung cancer2 recruiting
• Macular degeneration1 recruiting
• Polycystic ovary syndrome1 recruiting
• Stroke1 recruiting

Closed trials

• Completed

  Observational Study of the Use of Extraneal in Peritoneal Dialysis in Patients

  NCT06492031· Vantive Health LLC· Source

• Recruiting

  Identification for High Risk of Coronary Heart Disease Based on Quantitative Analysis of Fundus Vessels and Metabolic Molecules

  NCT07773064· Beijing Hospital· Source

• Completed

  Exploratory Study of the Microbiome of Upper Gastrointestinal in the Pathogenesis of Multiple Primary Lung Cancer

  NCT06973499· Beijing Haidian Hospital· Source

• Completed

  Value of Glycated Albumin in Intervention of Glycemic Control in Chinese Patients With Type 2 Diabetes

  NCT05227677· Asahi Kasei Therapeutics Corporation· Source